SCHEMBL2008700

SCHEMBL2008700

CCCCCCCC(=O)OC(=O)/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 0.74
ADORA3 P0DMS8 3/20 0.74
MAPT P10636 7/20 0.63
CYP3A4 P08684 6/20 0.63
RXRA P19793 5/20 0.63
RARA P10276 4/20 0.63
RARB P10826 4/20 0.63
RARG P13631 4/20 0.63
PTGS1 P23219 4/20 0.63
APP P05067 4/20 0.63
SNCA P37840 4/20 0.63
MAPK1 P28482 3/20 0.63
ALOX15 P16050 3/20 0.63
RXRB P28702 2/20 0.63
RXRG P48443 2/20 0.63
RORC P51449 2/20 0.63
HTR2B P41595 2/20 0.63
BLM P54132 2/20 0.63
HIF1A Q16665 2/20 0.63
DRD3 P35462 2/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2006702 1.00 ALDH1A1 (0.74) ALDH1A1ADORA3MAPTCYP3A4RXRA
SCHEMBL1895263 1.00 ALDH1A1 (0.74) ALDH1A1ADORA3MAPTCYP3A4RXRA
SCHEMBL2008326 1.00 ALDH1A1 (0.74) ALDH1A1ADORA3MAPTCYP3A4RXRA
SCHEMBL57568 1.00 ALDH1A1 (0.74) ALDH1A1ADORA3MAPTCYP3A4RXRA
SCHEMBL1695153 1.00 ALDH1A1 (0.74) ALDH1A1ADORA3MAPTCYP3A4RXRA
SCHEMBL3422972 1.00 ALDH1A1 (0.74) ALDH1A1ADORA3MAPTCYP3A4RXRA
SCHEMBL4399478 1.00 ALDH1A1 (0.74) ALDH1A1ADORA3MAPTCYP3A4RXRA
SCHEMBL2011547 1.00 ALDH1A1 (0.74) ALDH1A1ADORA3MAPTCYP3A4RXRA
SCHEMBL2005744 1.00 ALDH1A1 (0.74) ALDH1A1ADORA3MAPTCYP3A4RXRA
SCHEMBL2005804 1.00 ALDH1A1 (0.74) ALDH1A1ADORA3MAPTCYP3A4RXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 393 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4429972-B1 DUAL-UNIT PACK UNILEVER IP HOLDINGS B V (NL) 2025-04-23 EP claimed
EP-4429972-A1 DUAL-UNIT PACK Unilever IP Holdings B.V. (NL) 2024-09-18 EP claimed
CN-118251350-A Double unit package 联合利华知识产权控股有限公司 2024-06-25 CN claimed
WO-2023083683-A1 DUAL-UNIT PACK UNILEVER IP HOLDINGS B.V. (NL) 2023-05-19 WO claimed
WO-2023061371-A1 AEROSOLIZED VITAMIN A FOR MANAGEMENT OF COVID–19-RELATED OLFACTORY DYSFUNCTION VERSITECH LIMITED (CN) 2023-04-20 WO claimed
CN-107072902-B Use of cosmetic compositions comprising 10-hydroxystearic acid 帝斯曼知识产权资产管理有限公司 2021-01-19 CN claimed
EP-2869717-B1 PREVENTION OF ALCOHOL REACTION WITH DIETARY SUPPLEMENTS NOGLO LLC (US) 2018-06-13 EP claimed
CN-107072902-A The purposes of cosmetic composition comprising 10 hydroxy stearic acids 帝斯曼知识产权资产管理有限公司 2017-08-18 CN claimed
EP-2869717-A1 PREVENTION OF ALCOHOL REACTION WITH DIETARY SUPPLEMENTS Tolleth, Robert J. (US) 2015-05-13 EP claimed
WO-2014143192-A1 REDUCTION OR PREVENTION OF ALCOHOL REACTION WITH DIETARY SUPPLEMENTS NOGLO LLC (US) 2014-09-18 WO claimed
US-20040137024-A1 Smoothing out wrinkles with a fragrancing composition L'OREAL (FR) 2004-07-15 US claimed
EP-0793481-B1 COSMETIC COMPOSITION CONTAINING HYDROXY ALKANOATE DERIVATIVES UNILEVER PLC (GB) 2004-06-02 EP claimed
EP-1415644-A1 Cosmetic process for smoothing out expression wrinkles by topical application of a perfume composition L'OREAL (FR) 2004-05-06 EP claimed
US-20030224060-A1 Polyester polyol nanocapsules, compositions thereof, and methods of use L'OREAL (FR) 2003-12-04 US claimed
US-20030215413-A1 Compositions containing stabilized retinoid L'OREAL (FR) 2003-11-20 US claimed
EP-0970691-B1 Composition for topical application containing a lipase, vitamin precursor and a fatty alcohol OREAL (FR) 2003-07-16 EP claimed
US-6451330-B1 DIMINISHES THE APPEARANCE AND FEEL OF OILY SKIN AND IS CAPABLE OF DELIVERING BENEFITS ASSOCIATED WITH RETINOIDS UNILEVER HOME & PERSONAL CARE, USA, DIVISION OF CONOPCO, INC. 2002-09-17 US claimed
US-6153205-A Topical application product containing a lipase, a vitamin precursor and a fatty alcohol L'OREAL (FR) 2000-11-28 US claimed
US-5932232-A Product for topical application containing a lipase and an active ingredient precursor L'OREAL (FR) 1999-08-03 US claimed
EP-0710478-B1 Composition for topical application containing a lipase and an active agent precursor OREAL (FR) 1997-01-22 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030215413-A1 Compositions containing stabilized retinoid RARA, RARB, RARG ALDH1A1 450/4885ADORA3 1093/4885MAPT 2248/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.